Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 40)
CareView Communications, Inc.
(Name of Issuer)
Common Stock, $.001 Par Value Per Share
(Title Class of Securities)
141743104
(CUSIP Number)
HealthCor Management, L.P.
55 Hudson Yards, 28th Floor
New York, New York 10001
Attention: Laurie Hadick
(212) 622-7800
With a Copy to:
Eugene McDermott
Locke Lord LLP
2800 Financial Plaza
Providence, RI 02903
(401) 276-6471
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
July 12, 2022
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ¨
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
(1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 141743104 | 13D | Page 2 of 19 |
| (1) | NAME OF REPORTING PERSON HealthCor Management, L.P. |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
WC |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 21,890,263 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 21,890,263 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,890,263 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6% |
||
| (14) | TYPE OF REPORTING PERSON PN |
||
| CUSIP No. 141743104 | 13D | Page 3 of 19 |
| (1) | NAME OF REPORTING PERSON HealthCor Associates, LLC |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 21,890,263 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 21,890,263 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,890,263 | ||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6% | ||
| (14) | TYPE OF REPORTING PERSON OO- limited liability company | ||
| CUSIP No. 141743104 | 13D | Page 4 of 19 |
| (1) | NAME OF REPORTING PERSON HealthCor Hybrid Offshore Master Fund, L.P. |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 21,890,263 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 21,890,263 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,890,263 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6% |
||
| (14) | TYPE OF REPORTING PERSON PN |
||
| CUSIP No. 141743104 | 13D | Page 5 of 19 |
| (1) |
NAME OF REPORTING PERSON
HealthCor Hybrid Offshore GP, LLC |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 21,890,263 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 21,890,263 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,890,263 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6% |
||
| (14) | TYPE OF REPORTING PERSON OO-limited liability company |
||
| CUSIP No. 141743104 | 13D | Page 6 of 19 |
| (1) |
NAME OF REPORTING PERSON
HealthCor Group, LLC |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 21,890,263 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 21,890,263 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,890,263 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.6% |
||
| (14) | TYPE OF REPORTING PERSON OO-limited liability company |
||
| CUSIP No. 141743104 | 13D | Page 7 of 19 |
| (1) |
NAME OF REPORTING PERSON
HealthCor Partners Management, L.P. |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
WC |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 23,983,052 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 23,983,052 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,983,052 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.7% |
||
| (14) | TYPE OF REPORTING PERSON PN |
||
| CUSIP No. 141743104 | 13D | Page 8 of 19 |
| (1) |
NAME OF REPORTING PERSON
HealthCor Partners Management GP, LLC |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 23,983,052 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 23,983,052 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,983,052 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.7% |
||
| (14) | TYPE OF REPORTING PERSON OO- limited liability company |
||
| CUSIP No. 141743104 | 13D | Page 9 of 19 |
| (1) |
NAME OF REPORTING PERSON
HealthCor Partners Fund, L.P. |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 23,983,052 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 23,983,052 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,983,052 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.7% |
||
| (14) | TYPE OF REPORTING PERSON PN |
||
| CUSIP No. 141743104 | 13D | Page 10 of 19 |
| (1) |
NAME OF REPORTING PERSON
HealthCor Partners L.P. |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 23,983,052 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 23,983,052 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,983,052 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.7% |
||
| (14) | TYPE OF REPORTING PERSON PN |
||
| CUSIP No. 141743104 | 13D | Page 11 of 19 |
| (1) |
NAME OF REPORTING PERSON
HealthCor Partners GP, LLC |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 0 | ||
| (8) | SHARED VOTING POWER 23,983,052 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 23,983,052 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 23,983,052 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.7% |
||
| (14) | TYPE OF REPORTING PERSON OO- limited liability company |
||
| CUSIP No. 141743104 | 13D | Page 12 of 19 |
| (1) |
NAME OF REPORTING PERSON
Jeffrey C. Lightcap |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF, PF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 34,117,498 | ||
| (8) | SHARED VOTING POWER 23,983,052 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 23,983,052 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 58,100,550 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
29.4% |
||
| (14) | TYPE OF REPORTING PERSON IN |
||
| CUSIP No. 141743104 | 13D | Page 13 of 19 |
| (1) |
NAME OF REPORTING PERSON
Arthur Cohen |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF, PF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 3,985,881 | ||
| (8) | SHARED VOTING POWER 45,873,315 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 45,873,315 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 49,859,196 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
26.3% |
||
| (14) | TYPE OF REPORTING PERSON IN |
||
| CUSIP No. 141743104 | 13D | Page 14 of 19 |
| (1) |
NAME OF REPORTING PERSON
Joseph Healey |
||
| (2) |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ |
||
| (3) | SEC USE ONLY |
||
| (4) |
SOURCE OF FUNDS
AF, PF |
||
| (5) | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
¨ | |
| (6) |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(7) | SOLE VOTING POWER 2,937,397 | ||
| (8) | SHARED VOTING POWER 45,873,315 | |||
| (9) |
SOLE DISPOSITIVE POWER | |||
| (10) | SHARED DISPOSITIVE POWER 45,873,315 |
| (11) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 48,810,712 |
||
| (12) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|
¨ | |
| (13) |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
25.9% |
||
| (14) | TYPE OF REPORTING PERSON IN |
||
| CUSIP No. 141743104 | 13D | Page 15 of 19 |
This Amendment No. 40 to Schedule 13D (the “Amendment”) amends and supplements the beneficial ownership statement on Schedule 13D originally filed with the Securities and Exchange Commission on May 2, 2011, as amended by Amendment No. 1 filed October 3, 2011, Amendment No. 2 filed January 3, 2012, Amendment No. 3 filed February 2, 2012, Amendment No. 4 filed October 2, 2012, Amendment No. 5 filed April 5, 2013, Amendment No. 6 filed October 2, 2013, Amendment No. 7 filed January 3, 2014, Amendment No. 8 filed January 21, 2014, Amendment No. 9 filed July 1, 2014, Amendment No. 10 filed January 6, 2015, Amendment No. 11 filed February 20, 2015, Amendment No. 12 filed April 12, 2015, Amendment No. 13 filed July 6, 2015, Amendment No. 14 filed October 2, 2015, Amendment No. 15 filed January 4, 2016, Amendment No. 16 filed April 6, 2016, Amendment No. 17 filed July 1, 2016, Amendment No. 18 filed October 3, 2016, Amendment No. 19 filed January 3, 2017, Amendment No. 20 filed April 3, 2017, Amendment No. 21 filed July 5, 2017, Amendment No. 22 filed October 2, 2017, Amendment No. 23 filed January 3, 2018, Amendment No. 24 filed February 28, 2018, Amendment No. 25 filed July 17, 2018, Amendment No. 26 filed January 3, 2019, Amendment No. 27 filed May 17, 2019, Amendment No. 28 filed January 2, 2020, Amendment No. 29 filed February 10, 2020, Amendment No. 30 filed July 2, 2020, Amendment No. 31 filed October 2, 2020, Amendment No. 32 filed January 5, 2021, Amendment No. 33 filed April 1, 2021, Amendment No. 34 filed April 22, 2021, Amendment No. 35 filed July 1, 2021, Amendment No. 36 filed October 4, 2021, Amendment No. 37 filed January 4, 2022, Amendment No. 38 filed March 10, 2022 and Amendment No. 39 filed July 1, 2022 (collectively, the “Original Statement”). The persons filing this Amendment are HealthCor Management, L.P., HealthCor Associates, LLC, HealthCor Hybrid Offshore Master Fund, L.P., HealthCor Hybrid Offshore GP, LLC, HealthCor Group, LLC, HealthCor Partners Management, L.P., HealthCor Partners Management GP, LLC, HealthCor Partners Fund, L.P., HealthCor Partners, L.P., HealthCor Partners GP, LLC, Jeffrey C. Lightcap, Joseph Healey and Arthur Cohen. The Original Statement, as amended by this Amendment (the “Statement”), relates to the shares of Common Stock of CareView Communications, Inc., par value $0.001 (the "Common Stock").
Capitalized terms used herein but not defined shall have the meanings ascribed to them in the Original Statement. This Amendment amends the Original Statement as specifically set forth herein. Except as set forth below, all previous Items in the Original Statement remain unchanged.
The Amendment is being filed for the purpose of reflecting the amendments to the 2014 Notes, the 2015 Notes, the 2018 Notes, the Tenth Amendment Notes, the Twelfth Amendment Notes and the Thirteenth Amendment Notes held, in each case, by the Reporting Persons in order to suspend accrual of interest on such Notes held by the Reporting Persons as of December 31, 2021.
Item 5. Interest in Securities of the Issuer
Item 5 is hereby amended and restated in its entirety as follows:
(a) Collectively, the Reporting Persons beneficially own an aggregate of 86,914,091 shares of Common Stock, representing (i) 12,633,454 shares of Common Stock that may be acquired upon conversion of the Thirteenth Amendment Notes (including interest paid in kind through December 31, 2021), (ii) 2,302,971 shares of Common Stock that may be acquired upon conversion of the Twelfth Amendment Notes (including interest paid in kind through December 31, 2021), (iii) 7,659,596 shares of Common Stock that may be acquired upon conversion of the Tenth Amendment Notes (including interest paid in kind through December 31, 2021), (iv) 8,032,014 shares of Common Stock that may be acquired upon conversion of the 2018 Notes (including interest paid in kind through December 31, 2021), (v) 13,329,493 shares of Common Stock that may be acquired upon conversion of the 2015 Notes (including interest paid in kind through December 31, 2021), (vi) 30,977,654 shares of Common Stock that may be acquired upon conversion of the 2014 Notes (including interest paid in kind through December 31, 2021), (vii) 4,000,000 shares of Common Stock that may be acquired upon exercise of the 2014 Warrants, (viii) 1,916,409 shares of Common Stock that may be acquired upon exercise of the 2015 Warrants, (ix) 1,000,000 shares of Common Stock that may be acquired upon exercise of the Sixth Amendment Warrants, (x) 62,500 shares of Common Stock that may be acquired upon exercise of the 2018 Warrants, (xi) 2,000,000 shares of Common Stock that may be acquired upon exercise of the 2021 Warrants and (xii) 3,000,000 shares of Common Stock that may be acquired upon exercise of the 2022 Warrants (the 2014 Warrants, the 2015 Warrants, the Sixth Amendment Warrants, the 2018 Warrants, the 2021 Warrants and the 2022 Warrants together, the “Warrants”). This aggregate amount represents approximately 38.4% of the Issuer’s outstanding common stock, based upon 139,380,748 shares outstanding as of May 23, 2022, as reported in the Issuer’s most recent Quarterly Report on Form 10-Q, and gives effect to the conversion of all 2014 Notes, 2015 Notes, 2018 Notes, Tenth Amendment Notes, Twelfth Amendment Notes and Thirteenth Amendment Notes held by the Reporting Persons into Common Stock (giving effect to the amendments described in Item 6 below) and the exercise of all Warrants held by the Reporting Persons.
| CUSIP No. 141743104 | 13D | Page 16 of 19 |
Of the amount beneficially owned by the Reporting Persons:
(i) HCP Fund is the beneficial owner of (A) 4,280,277 shares of Common Stock underlying the current principal amount of the 2015 Note issued to it (including interest paid in kind through December 31, 2021), (B) 14,429,391 shares of Common Stock underlying the current principal amount of the 2014 Note issued to it (including interest paid in kind through December 31, 2021), (C) 1,397,400 shares of Common Stock that it has a right to acquire upon exercise of its 2022 Warrant, (D) 931,600 shares of Common Stock that it has a right to acquire upon exercise of its 2021 Warrant, (E) 465,800 shares of Common Stock that it has a right to acquire upon exercise of its Sixth Amendment Warrant, (F) 615,384 shares of Common Stock that it has a right to acquire upon exercise of its 2015 Warrant, and (G) 1,863,200 shares of Common Stock that it has a right to acquire upon exercise of its 2014 Warrant;
(ii) By virtue of their relationship to HCP Fund, described in more detail under Item 2 of this Statement, each of HealthCor Partners, L.P., HCPGP, HealthCor Partners Management, L.P., and HCPMGP may be deemed to share beneficial ownership with HCP Fund of the shares of Common Stock beneficially owned by the HCP Fund;
(iii) Hybrid Fund is the beneficial owner of (A) 16,548,263 shares of Common Stock underlying the current principal amount of the 2014 Note issued to it (including interest paid in kind through December 31, 2021), (B) 1,602,600 shares of Common Stock that it has a right to acquire upon exercise of its 2022 Warrant, (C) 1,068,400 shares of Common Stock that it has a right to acquire upon exercise of its 2021 Warrant, (D) 534,200 shares of Common Stock that it has a right to acquire upon exercise of its Sixth Amendment Warrant, and (E) 2,136,800 shares of Common Stock that it has a right to acquire upon exercise of its 2014 Warrant;
(iv) By virtue of their relationship to Hybrid Fund, described in more detail under Item 2 of this Statement, each of Offshore GP, Group, HealthCor Management, L.P., and Associates may be deemed to share beneficial ownership with Hybrid Fund of the shares of Common Stock beneficially owned by Hybrid Fund;
(v) By virtue of his relationship to HCP Fund, Mr. Lightcap may be deemed to share beneficial ownership of the shares of Common Stock beneficially owned by HCP Fund. In addition, Mr. Lightcap is the beneficial owner of (A) 12,633,454 shares of Common Stock underlying the principal amount of the Thirteenth Amendment Note purchased by him under the Thirteenth Amendment (including interest paid in kind through December 31, 2021), (B) 2,302,971 shares of Common Stock underlying the principal amount of the Twelfth Amendment Note purchased by him under the Twelfth Amendment (including interest paid in kind through December 31, 2021); (C) 7,659,596 shares of Common Stock underlying the current principal amount of the Tenth Amendment Note purchased by him pursuant to the Tenth Amendment (including interest paid in kind through December 31, 2021); (D) 8,032,014 shares of Common Stock underlying the current principal amount of the 2018 Note purchased by him under the Eighth Amendment (including interest paid in kind through December 31, 2021), (E) 2,996,194 shares of Common Stock underlying the current principal amount of the 2015 Note purchased by him under the Fifth Amendment (including interest paid in kind through December 31, 2021), (F) 62,500 shares of Common Stock that he has a right to acquire upon exercise of his 2018 Warrant and (G) 430,769 shares of Common Stock that he has a right to acquire upon exercise of his 2015 Warrant;
| CUSIP No. 141743104 | 13D | Page 17 of 19 |
(vi) By virtue of his relationship to HCP Fund and Hybrid Fund, Mr. Cohen may be deemed to share beneficial ownership of the shares of Common Stock beneficially owned by each of the Funds. In addition, Mr. Cohen is the beneficial owner of (A) 3,484,856 shares of Common Stock underlying the current principal amount of the 2015 Note purchased by him under the Fifth Amendment (including interest paid in kind through December 31, 2021) and (B) 501,025 shares of Common Stock that he has a right to acquire upon exercise of his 2015 Warrant; and
(vii) By virtue of his relationship to HCP Fund and Hybrid Fund, Mr. Healey may be deemed to share beneficial ownership of the shares of Common Stock beneficially owned by each of the Funds. In addition, Mr. Healey is the beneficial owner of (A) 2,568,166 shares of Common Stock underlying the current principal amount of the 2015 Note purchased by him under the Fifth Amendment (including interest paid in kind through December 31, 2021) and (B) 369,231 shares of Common Stock that he has a right to acquire upon exercise of his 2015 Warrant.
The filing of this Statement shall not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, the beneficial owner of any of the shares of Common Stock owned by the Funds or any other Reporting Person. Pursuant to Rule 13d-4, each of the Reporting Persons disclaims such beneficial ownership.
(b) The information in Items 7 through 10 of each cover page to this Statement is incorporated by reference into this Item 5(b).
(c) Except for the amendments to certain Notes described under Item 6, the Reporting Persons have effected no transactions relating to the Common Stock since their most recent amendment to the Original Statement.< /p>
(d)-(e) Inapplicable.
Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
Item 6 is hereby amended and supplemented as follows:
On July 12, 2022, the Reporting Persons entered into amendments to the 2014 Notes, the 2015 Notes, the 2018 Notes, the Tenth Amendment Notes, the Twelfth Amendment Notes and the Thirteenth Amendment Notes that suspend the accrual of interest on the Notes of each such class held by the Reporting Persons from and after January 1, 2022.
Item 7. MATERIAL TO BE FILED AS EXHIBITS
Item 7 is hereby supplemented as follows:
| Exhibit No. | Description |
| 64 | Allonge No. 3 to 2014 Notes (incorporated by reference from Exhibit 10.41 to the Issuer’s Current Report on Form 8-K filed July 12, 2022). |
| 65 | Allonge No. 3 to 2015 Notes (incorporated by reference from Exhibit 10.42 to the Issuer’s Current Report on Form 8-K filed July 12, 2022). |
| 66 | Allonge No. 2 to 2018 Notes (incorporated by reference from Exhibit 10.43 to the Issuer’s Current Report on Form 8-K filed July 12, 2022). |
| 67 | Allonge No. 1 to Tenth Amendment Notes, Twelfth Amendment Notes and Thirteenth Amendment Notes (incorporated by reference from Exhibit 10.44 to the Issuer’s Current Report on Form 8-K filed July 12, 2022). |
| CUSIP No. 141743104 | 13D | Page 18 of 19 |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
July 15, 2022
| HEALTHCOR MANAGEMENT, L.P. | |||
| By: HealthCor Associates, LLC, its general partner | |||
| By: | /s/ Laurie Hadick | ||
| Name: Laurie Hadick | |||
| Title: Chief Compliance Officer | |||
| HEALTHCOR HYBRID OFFSHORE GP, LLC, for itself and as general partner on behalf of HEALTHCOR HYBRID OFFSHORE MASTER FUND, L.P. | |||
| By: HealthCor Group, LLC, its general partner | |||
| By: | /s/ Laurie Hadick | ||
| Name: Laurie Hadick | |||
| Title: Chief Compliance Officer | |||
| HEALTHCOR ASSOCIATES, LLC | |||
| By: | /s/ Laurie Hadick | ||
| Name: Laurie Hadick | |||
| Title: Chief Compliance Officer | |||
| HEALTHCOR GROUP, LLC | |||
| By: | /s/ Laurie Hadick | ||
| Name: Laurie Hadick | |||
| Title: Chief Compliance Officer | |||
| CUSIP No. 141743104 | 13D | Page 19 of 19 |
| HEALTHCOR PARTNERS MANAGEMENT, L.P. | |||
| By: HealthCor Partners Management GP, LLC, its general partner | |||
| By: | /s/ Jeffrey C. Lightcap | ||
| Name: Jeffrey C. Lightcap | |||
| Title: Member | |||
| HEALTHCOR PARTNERS MANAGEMENT GP, LLC | |||
| By: | /s/ Jeffrey C. Lightcap | ||
| Name: Jeffrey C. Lightcap | |||
| Title: Member | |||
| HEALTHCOR PARTNERS L.P., for itself and as general partner on behalf of HEALTHCOR PARTNERS FUND, L.P. | |||
| By: HealthCor Partners GP, LLC, its general partner | |||
| By: | /s/ Jeffrey C. Lightcap | ||
| Name: Jeffrey C. Lightcap | |||
| Title: Member | |||
| HEALTHCOR PARTNERS GP, LLC | |||
| By: | /s/ Jeffrey C. Lightcap | ||
| Name: Jeffrey C. Lightcap | |||
| Title: Member | |||
| JEFFREY C. LIGHTCAP, Individually | |||
| /s/ Jeffrey C. Lightcap | |||
| JOSEPH HEALEY, Individually | |||
| /s/ Joseph Healey | |||
| ARTHUR COHEN, Individually | |||
| /s/ Arthur Cohen | |||